Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis

doi:10.3748/wjg.v11.i46.7364

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2648)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

258

HTML

2029

Figures (1-2)

361

Sum=2648

Dec 14, 2005 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 14, 2005; 11(46): 7364-7367
Published online Dec 14, 2005. doi: 10.3748/wjg.v11.i46.7364

Full Size Figure Download Figure

Figure 2 Plasma or serum levels of PAF (A), MDA (B) and TNF-α (C) in patients and controls. The values of PAF, TNF-α and MDA in patients with hepatitis were significantly higher than those in controls (P<0.01). ^aP<0.05 vs group 3, ^cP>0.05 vs group 4, ^eP>0.05 vs every two groups in groups 1-4.

Citation: Cao HC, Chen XM, Xu W. Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis. World J Gastroenterol 2005; 11(46): 7364-7367
URL: https://www.wjgnet.com/1007-9327/full/v11/i46/7364.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i46.7364